Flavonoid-enriched extract from hippophae rhamnoides seed reduces high fat diet induced obesity, hypertriglyceridemia, and hepatic triglyceride accumulation in C57BL/6 mice

Pharmaceutical Biology

Volumn 55, Issue 1, 2017, Pages 1207-1214

  Yang, Xin ^a   Wang, Qian ^b   Pang, Zeng Run ^a   Pan, Meng Ran ^a   Zhang, Wen ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Inflammation; Obese mice; PPAR ; PPAR

Indexed keywords

FLAVONOID; PLANT EXTRACT; TRIACYLGLYCEROL;

ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BODY WEIGHT; C57BL MOUSE; DRUG EFFECTS; HIPPOPHAE; HYPERTRIGLYCERIDEMIA; ISOLATION AND PURIFICATION; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; OBESITY; PHYSIOLOGY; PLANT SEED;

ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; FLAVONOIDS; HIPPOPHAE; HYPERTRIGLYCERIDEMIA; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PLANT EXTRACTS; SEEDS; TRIGLYCERIDES;

EID: 85015348184     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880209.2016.1278454     Document Type: Article

References (26)

1. Anghel SI, Wahli W. 2007. Fat poetry: a kingdom for PPAR gamma. Cell Res. 17:486-511.
2. Basu M, Prasad R, Jayamurthy P, Pal K, Arumughan C, Sawhney RC. 2007. Anti-atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil. Phytomedicine. 14:770-777.
3. Cheng J, Kondo K, Suzuki Y, Ikeda Y, Meng X, Umemura K. 2003. Inhibitory effects of total flavones of Hippophae rhamnoides L. on thrombosis in mouse femoral artery and in vitro platelet aggregation. Life Sci. 72:2263-2271.
4. Chinese Pharmacopoeia Commission 2010. Chinese material medica and prepared slices of Chinese crude drugs In: Chinese Pharmacopoeia Commission, editor. The Chinese Pharmacopoeia 2010 Edition. Beijing, China: China Medical Science Press, vol. I: 171-2.
5. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. 2009. Adipogenesis and WNT signalling. Trends Endocrinol Metab. 20:16-24.
6. Day CP, Saksena S. 2002. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol. 17(Suppl 3):S377-S384.
7. Fruchart JC. 2009. Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis. 205:1-8.
8. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 280:E827-E847.
9. Geetha S, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. 2002. Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides)-an in vitro study. J Ethnopharmacol. 79:373-378.
10. Gesta S, Tseng YH, Kahn CR. 2007. Developmental origin of fat: tracking obesity to its source. Cell. 131:242-256.
11. Hemmeryckx B, Hoylaerts MF, Gallacher DJ, Rong Lu H, Himmelreich U, D'Hooge J, Swinnen M, Lijnen HR. 2013. Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice? Eur J Pharmacol. 700:23-31.
12. Jeong S, Yoon M. 2009. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med. 41:397-405.
13. Koeck ES, Iordanskaia T, Sevilla S, Ferrante SC, Hubal MJ, Freishtat RJ, Nadler EP. 2014. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. J Surg Res. 192:268-275.
14. MacDougald OA, Mandrup S. 2002. Adipogenesis: forces that tip the scales. Trends Endocrinol Metab. 13:5-11.
15. Maheshwari DT, Yogendra Kumar MS, Verma SK, Singh VK, Singh SN. 2011. Antioxidant and hepatoprotective activities of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves. Food Chem Toxicol. 49:2422-2428.
16. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF. 2002. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes. 51:797-802.
17. Okabe T, Toda T, Nukitrangsan N, Inafuku M, Iwasaki H, Oku H. 2011. Peucedanum japonicum Thunb inhibits high-fat diet induced obesity in mice. Phytother Res. 25:870-877.
18. Pang X, Zhao J, Zhang W, Zhuang X, Wang J, Xu R, Xu Z, Qu W. 2008. Antihypertensive effect of total flavones extracted from seed residues of Hippophae rhamnoides L. in sucrose-fed rats. J Ethnopharmacol. 117:325-331.
19. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell. 104:531-543.
20. Suleyman H, Demirezer LO, Buyukokuroglu ME, Akcay MF, Gepdiremen A, Banoglu ZN, Gocer F. 2001. Antiulcerogenic effect of Hippophae rhamnoides L. Phytother Res. 15:625-627.
21. Sundaresan A, Radhiga T, Pugalendi KV. 2014. Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice. Eur J Pharmacol. 741:297-303.
22. van de Woestijne AP, Monajemi H, Kalkhoven E, Visseren FL. 2011. Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev. 12:829-840.
23. Wang J, Zhang W, Zhu D, Zhu X, Pang X, Qu W. 2011. Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet. J Sci Food Agric. 91:1446-1451.
24. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112:1796-1808.
25. Yoon M. 2009. The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res. 60:151-159.
26. Yu J, Shen J, Sun TT, Zhang X, Wong N. 2013. Obesity, insulin resistance, NASH and hepatocellular carcinoma. Semin Cancer Biol. 23:483-491.